Well people hate it when anyone contradicts their deeply held belief. I speak on the strength of my professional experience in pharma research. I have met Jackey Fairley the CEO many years back. While she is a sharp lady the fact remains that BV like any other bacterial -itis is eminently treatable with the right regimen of antibacterials, so you dont need a fancy dendrimer for that. Secondly there is little known about what is special about dendrimers that other organic molecules can't do. Check it out -how many other groups are working on dendrimers for pharmaceuticals around the world? If they were that hot you would expect many research groups hot in pursuit wouldnt you?
Feel free if you want to buy more. Do your own research and make your own decisions. What I state is just for consideration.
- Forums
- ASX - By Stock
- SPL
- Ann: VivaGel phase 3 study results
Ann: VivaGel phase 3 study results , page-13
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $39.64M |
Open | High | Low | Value | Volume |
9.7¢ | 9.7¢ | 9.5¢ | $19.64K | 204.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 69731 | 9.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.7¢ | 5390 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 69731 | 0.095 |
2 | 305855 | 0.094 |
2 | 320000 | 0.093 |
1 | 100000 | 0.092 |
4 | 49861 | 0.090 |
Price($) | Vol. | No. |
---|---|---|
0.097 | 5390 | 1 |
0.098 | 200000 | 1 |
0.100 | 106000 | 3 |
0.105 | 148467 | 3 |
0.110 | 183058 | 5 |
Last trade - 16.10pm 09/09/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |